3,010 press releases indexed under healthcare.
Quantum Insights GmbH announced AURA, an AI-powered analytics platform for clinical research labs that reduces time-to-insight on multi-omics datasets by up to 70% while keeping patient data on-premises. The platform integrates with existing LIMS and ELN systems and is available immediately through a tiered subscription
NEW YORK, July 9, 2026 /PRNewswire/ -- Solaris Energy Infrastructure Inc. (NYSE: SEI) will replace Catalyst Pharmaceuticals Inc. (NASD: CPRX) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 15. Angelini Pharma S.p.A. is acquiring Catalyst...
Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia Transaction expected to provide HCC Healthcare with access to public capital markets to accelerate growth in integrated medical and long-term care services across Asia
(PR-inside.com) "Dr. Kenneth Finn, former President of the American Board of Pain Medicine, testified that today's state 'medical marijuana' system is a 'ruse'-one where the clinical evidence is lacking and standards are missing, as he reminisced of the old pill mills" stated Duane Boise CEO MMJ International Holdings. WASHINGTON, D.C. / ACCESS Newswire / July 9, 2026 / Day seven of the Drug Enforcement Administration's marijuana rescheduling hearing produced some of the most pointed testimony yet against the government's effort to move marijuana to Schedule III - and it came from a board certified pain physician the court accepted as an expert. Kenneth ..
"Dr. Kenneth Finn, former President of the American Board of Pain Medicine, testified that today's state 'medical marijuana' system is a 'ruse'-one where the clinical evidence is lacking and standards are missing, as he r eminisced of the old pill mills " stated Duane Boise CEO MMJ International Holdings.
2025 Results: -31% CO2e, 54% electricity from renewable sources, -63% lost time incident rate Ambitious CO2e reduction target of -52% by 2030 DUSSELDORF, GERMANY - July 9, 2026 ( NEWMEDIAWIRE ) - Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech, and cosmetics industries, has published its first voluntary separate Non-financial Report for the 2025 financial year, aligned with the Corporate Sustainability Reporting Directive (CSRD). The audited report transparently details the Group’s sustainability performance in financial year 2025. Gerresheimer was able to reduce its scope 1 and scope 2 CO2e emissions by 31% compared to the base year 2019 and increase the share of electricity from renewable sources in its total electricity consumption to
BIRMINGHAM, Ala., July 9, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will report results for its second quarter ended June 30, 2026, after the market closes on Wednesday, Aug. 5, 2026. The Company will host an investor conference call at 10 a.m. ET on...
Daix (France), New York City (New York, United States), July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of metabolic dysfunction-associated steatohepatitis (“ MASH ”), is pleased to announce the completion of the final step of the transactions previously announced on June 2, 2026 (the “ Combined Transaction ”) through the issuance of approximately 15.7 million new warrants ( bons de souscription d’actions ) (the " New EIB Warrants ") to the European Investment Bank (the " EIB ") and the surrender and cancellation of all remaining warrants originally issued to the EIB in January 2024 (the “ Legacy EIB Tranche B Warrants ”) that were not rep